These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36668853)

  • 21. Selective Targeting of Nav1.7 with Engineered Spider Venom-Based Peptides.
    Neff RA; Wickenden AD
    Channels (Austin); 2021 Dec; 15(1):179-193. PubMed ID: 33427574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant PaurTx-3, a spider toxin, inhibits sodium channels and decreases membrane excitability in DRG neurons.
    Chen M; Peng S; Wang L; Yang L; Si Y; Zhou X; Zhang Y; Liu Z
    Biochem Biophys Res Commun; 2020 Dec; 533(4):958-964. PubMed ID: 33004176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V.
    Moyer BD; Murray JK; Ligutti J; Andrews K; Favreau P; Jordan JB; Lee JH; Liu D; Long J; Sham K; Shi L; Stöcklin R; Wu B; Yin R; Yu V; Zou A; Biswas K; Miranda LP
    PLoS One; 2018; 13(5):e0196791. PubMed ID: 29723257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Manipulation of a spider peptide toxin alters its affinity for lipid bilayers and potency and selectivity for voltage-gated sodium channel subtype 1.7.
    Agwa AJ; Tran P; Mueller A; Tran HNT; Deuis JR; Israel MR; McMahon KL; Craik DJ; Vetter I; Schroeder CI
    J Biol Chem; 2020 Apr; 295(15):5067-5080. PubMed ID: 32139508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subtype specificity of scorpion beta-toxin Tz1 interaction with voltage-gated sodium channels is determined by the pore loop of domain 3.
    Leipold E; Hansel A; Borges A; Heinemann SH
    Mol Pharmacol; 2006 Jul; 70(1):340-7. PubMed ID: 16638971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gating modifier toxins isolated from spider venom: Modulation of voltage-gated sodium channels and the role of lipid membranes.
    Agwa AJ; Peigneur S; Chow CY; Lawrence N; Craik DJ; Tytgat J; King GF; Henriques ST; Schroeder CI
    J Biol Chem; 2018 Jun; 293(23):9041-9052. PubMed ID: 29703751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineering Highly Potent and Selective Microproteins against Nav1.7 Sodium Channel for Treatment of Pain.
    Shcherbatko A; Rossi A; Foletti D; Zhu G; Bogin O; Galindo Casas M; Rickert M; Hasa-Moreno A; Bartsevich V; Crameri A; Steiner AR; Henningsen R; Gill A; Pons J; Shelton DL; Rajpal A; Strop P
    J Biol Chem; 2016 Jul; 291(27):13974-13986. PubMed ID: 27129258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computational design of peptides to target Na
    Nguyen PT; Nguyen HM; Wagner KM; Stewart RG; Singh V; Thapa P; Chen YJ; Lillya MW; Ton AT; Kondo R; Ghetti A; Pennington MW; Hammock B; Griffith TN; Sack JT; Wulff H; Yarov-Yarovoy V
    Elife; 2022 Dec; 11():. PubMed ID: 36576241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical engineering and structural and pharmacological characterization of the α-scorpion toxin OD1.
    Durek T; Vetter I; Wang CI; Motin L; Knapp O; Adams DJ; Lewis RJ; Alewood PF
    ACS Chem Biol; 2013; 8(6):1215-22. PubMed ID: 23527544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural mutations change the affinity of μ-theraphotoxin-Hhn2a to voltage-gated sodium channels.
    Zhang F; Liu Y; Zhang C; Li J; Yang Z; Gong X; Gan Y; Chen P; Liu Z; Liang S
    Toxicon; 2015 Jan; 93():24-30. PubMed ID: 25447770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ts17, a Tityus serrulatus β-toxin structurally related to α-scorpion toxins.
    Menezes LFS; Maranhão MM; Tibery DV; de Souza ACB; da Mata DO; Campos LA; Souza AA; Freitas SM; Schwartz EF
    Biochim Biophys Acta Biomembr; 2023 Jan; 1865(1):184057. PubMed ID: 36240866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The structure, dynamics and selectivity profile of a NaV1.7 potency-optimised huwentoxin-IV variant.
    Rahnama S; Deuis JR; Cardoso FC; Ramanujam V; Lewis RJ; Rash LD; King GF; Vetter I; Mobli M
    PLoS One; 2017; 12(3):e0173551. PubMed ID: 28301520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical Synthesis, Proper Folding, Na
    Nicolas S; Zoukimian C; Bosmans F; Montnach J; Diochot S; Cuypers E; De Waard S; Béroud R; Mebs D; Craik D; Boturyn D; Lazdunski M; Tytgat J; De Waard M
    Toxins (Basel); 2019 Jun; 11(6):. PubMed ID: 31234412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seven novel modulators of the analgesic target NaV 1.7 uncovered using a high-throughput venom-based discovery approach.
    Klint JK; Smith JJ; Vetter I; Rupasinghe DB; Er SY; Senff S; Herzig V; Mobli M; Lewis RJ; Bosmans F; King GF
    Br J Pharmacol; 2015 May; 172(10):2445-58. PubMed ID: 25754331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rational Engineering Defines a Molecular Switch That Is Essential for Activity of Spider-Venom Peptides against the Analgesics Target NaV1.7.
    Klint JK; Chin YK; Mobli M
    Mol Pharmacol; 2015 Dec; 88(6):1002-10. PubMed ID: 26429937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Pivotal Potentials of Scorpion
    Richard SA; Kampo S; Sackey M; Hechavarria ME; Buunaaim ADB
    Evid Based Complement Alternat Med; 2020; 2020():4234273. PubMed ID: 33178316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineering potent and selective analogues of GpTx-1, a tarantula venom peptide antagonist of the Na(V)1.7 sodium channel.
    Murray JK; Ligutti J; Liu D; Zou A; Poppe L; Li H; Andrews KL; Moyer BD; McDonough SI; Favreau P; Stöcklin R; Miranda LP
    J Med Chem; 2015 Mar; 58(5):2299-314. PubMed ID: 25658507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct evidence for high affinity blockade of Na
    Gonçalves TC; Boukaiba R; Molgó J; Amar M; Partiseti M; Servent D; Benoit E
    Neuropharmacology; 2018 May; 133():404-414. PubMed ID: 29474819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analgesic Effects of Topical Amitriptyline in Patients With Chemotherapy-Induced Peripheral Neuropathy: Mechanistic Insights From Studies in Mice.
    Genevois AL; Ruel J; Penalba V; Hatton S; Petitfils C; Ducrocq M; Principe P; Dietrich G; Greco C; Delmas P
    J Pain; 2021 Apr; 22(4):440-453. PubMed ID: 33227509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. General mechanism of spider toxin family I acting on sodium channel Nav1.7.
    Yuan FC; Sun FD; Zhang L; Huang B; An HL; Rong MQ; Du CW
    Zool Res; 2022 Sep; 43(5):886-896. PubMed ID: 36052553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.